Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2010

01.10.2010 | Brief Report

Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision

verfasst von: Isacco Montroni, Donatella Santini, Giorgia Zucchini, Monica Fiacchi, Simone Zanotti, Giampaolo Ugolini, Alessio Manaresi, Mario Taffurelli

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Nipple discharge (ND) is a common symptom seen in breast cancer clinics. The primary aim of this study was to identify preoperative risk factors for breast cancer in patients with pathologic ND. The secondary aim was to assess the clinical and pathological effectiveness of physical examination, galactography, cytological examination of the discharge, selective duct excision and ductoscopy. All patients operated on between 1975 and 2008 who presented with ND as their only symptom was analyzed. Discharge’s characteristics, cytological data and galactography reports were recorded. The relationship between each individual finding and the risk of breast cancer was calculated. For each diagnostic tool, the sensitivity, specificity and complication rates were calculated and compared. Nine-hundred-fifteen patients underwent selective duct excision. Two-hundred-nineteen patients (23.9%) were found to be affected by carcinoma. In 100/330 (30.3%) patients with bloody discharge and in 42/239 (17.6%) patients with serous secretion cancer was detected (P = 0.004, P = 0.013, respectively). Patients with sero-sanguinous or coloured discharge had the same risk of cancer as the population analyzed (23.9%, P = NS). Galactographic finding of irregular stenosis seemed to be associated with a higher risk of cancer (P = 0.0001). Cytological findings C5 and C4 were associated with cancer (P = 0.001). Selective duct excision showed highest sensitivity and specificity. In conclusion, the well established role of bloody secretion is confirmed. The supposed benign aetiology of serous, coloured or sero-sanguinous discharge is questionable. The high specificity of the cytological exam justifies routine examination of the ND. Selective duct excision can be considered as the diagnostic gold-standard.
Literatur
1.
Zurück zum Zitat Gulay H, Bora S, Kilicturgay S et al (1994) Management of nipple discharge. J Am Coll Surg 178:471–474PubMed Gulay H, Bora S, Kilicturgay S et al (1994) Management of nipple discharge. J Am Coll Surg 178:471–474PubMed
2.
Zurück zum Zitat Murphy IG, Dillon MF, O’Doherty A et al (2007) Analysis of patients with false negative mammography and symptomatic breast carcinoma. J Surg Oncol 96:457–463CrossRefPubMed Murphy IG, Dillon MF, O’Doherty A et al (2007) Analysis of patients with false negative mammography and symptomatic breast carcinoma. J Surg Oncol 96:457–463CrossRefPubMed
3.
Zurück zum Zitat Vargas HI, Vargas MP, Eldrageely K et al (2006) Outcomes of clinical and surgical assessment of women with pathological nipple discharge. Am Surg 72:124–128PubMed Vargas HI, Vargas MP, Eldrageely K et al (2006) Outcomes of clinical and surgical assessment of women with pathological nipple discharge. Am Surg 72:124–128PubMed
4.
Zurück zum Zitat Hussain AN, Policarpio C, Vincent MT (2006) Evaluating nipple discharge. Obstet Gynecol Surv 61:278–283CrossRefPubMed Hussain AN, Policarpio C, Vincent MT (2006) Evaluating nipple discharge. Obstet Gynecol Surv 61:278–283CrossRefPubMed
5.
Zurück zum Zitat Sauter ER, Schlatter L, Lininger J et al (2004) The association of bloody nipple discharge with breast pathology. Surgery 136:780–785CrossRefPubMed Sauter ER, Schlatter L, Lininger J et al (2004) The association of bloody nipple discharge with breast pathology. Surgery 136:780–785CrossRefPubMed
6.
Zurück zum Zitat Simmons R, Adamovich T, Brennan M et al (2003) Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol 10:113–116CrossRefPubMed Simmons R, Adamovich T, Brennan M et al (2003) Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol 10:113–116CrossRefPubMed
7.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J et al (2002) Global cancer statistics. CA Cancer J Clin 55(2):74–108CrossRef Parkin DM, Bray F, Ferlay J et al (2002) Global cancer statistics. CA Cancer J Clin 55(2):74–108CrossRef
8.
Zurück zum Zitat King TA, Carter KM, Bolton JS et al (2000) A simple approach to nipple discharge. Am Surg 66:960–966PubMed King TA, Carter KM, Bolton JS et al (2000) A simple approach to nipple discharge. Am Surg 66:960–966PubMed
9.
Zurück zum Zitat Murad TM, Contesso G, Mouriesse H (1982) Nipple discharge from the breast. Ann Surg 195:259–264CrossRefPubMed Murad TM, Contesso G, Mouriesse H (1982) Nipple discharge from the breast. Ann Surg 195:259–264CrossRefPubMed
10.
Zurück zum Zitat Kapenhas-Valdes E, Feldman SM, Boolbol SK (2008) The role of mammary ductoscopy in breast cancer: a review of the literature. Ann Surg Oncol 15:3350–3360CrossRefPubMed Kapenhas-Valdes E, Feldman SM, Boolbol SK (2008) The role of mammary ductoscopy in breast cancer: a review of the literature. Ann Surg Oncol 15:3350–3360CrossRefPubMed
11.
Zurück zum Zitat Dixon JM, Mansel RE (1994) ABC of breast diseases: symptoms assessment and guidelines for referral. BMJ 309:722–726PubMed Dixon JM, Mansel RE (1994) ABC of breast diseases: symptoms assessment and guidelines for referral. BMJ 309:722–726PubMed
12.
Zurück zum Zitat Adepoju LJ, Chun J, El-Tamer M et al (2005) The value of clinical characteristics and breast-imaging studies in predicting a histopathologic diagnosis of cancer or high risk lesion in patients with spontaneous nipple discharge. Am J Surg 190:644–646CrossRefPubMed Adepoju LJ, Chun J, El-Tamer M et al (2005) The value of clinical characteristics and breast-imaging studies in predicting a histopathologic diagnosis of cancer or high risk lesion in patients with spontaneous nipple discharge. Am J Surg 190:644–646CrossRefPubMed
13.
Zurück zum Zitat Dinkel HP, Gassel AM, Muller T et al (2001) Galactography and exfoliative cytology in women with abnormal nipple discharge. Obstet Gynecol 97:625–629CrossRefPubMed Dinkel HP, Gassel AM, Muller T et al (2001) Galactography and exfoliative cytology in women with abnormal nipple discharge. Obstet Gynecol 97:625–629CrossRefPubMed
14.
Zurück zum Zitat Florio MG, Manganaro T, Pollicino A et al (1999) Surgical approach to nipple discharge: a ten-year experience. J Surg Oncol 71:235–238CrossRef Florio MG, Manganaro T, Pollicino A et al (1999) Surgical approach to nipple discharge: a ten-year experience. J Surg Oncol 71:235–238CrossRef
15.
Zurück zum Zitat Locker AP, Galea MH, Ellis IO et al (1988) Microdochectomy for single duct discharge from the nipple. Br J Surg 75:700–701CrossRefPubMed Locker AP, Galea MH, Ellis IO et al (1988) Microdochectomy for single duct discharge from the nipple. Br J Surg 75:700–701CrossRefPubMed
16.
Zurück zum Zitat Masanori H, Hiroshi N, Takehiko G (2007) MR ductography: comparison with conventional ductography as a diagnostic method in patients with nipple discharge. RadioGraphics 27:183–196CrossRef Masanori H, Hiroshi N, Takehiko G (2007) MR ductography: comparison with conventional ductography as a diagnostic method in patients with nipple discharge. RadioGraphics 27:183–196CrossRef
17.
Zurück zum Zitat National Task Force for Breast Cancer Autori (2007) FONCAM guidelines for breast pathology. Florence, Italy. Mancano le pagine National Task Force for Breast Cancer Autori (2007) FONCAM guidelines for breast pathology. Florence, Italy. Mancano le pagine
18.
Zurück zum Zitat Louie LD, Crowe JP, Dawson AE et al (2006) Identification of breast cancer in patients with pathologic nipple discharge: does ductoscopy predict malignancy? Am J Surg 192(4):530–533CrossRefPubMed Louie LD, Crowe JP, Dawson AE et al (2006) Identification of breast cancer in patients with pathologic nipple discharge: does ductoscopy predict malignancy? Am J Surg 192(4):530–533CrossRefPubMed
19.
Zurück zum Zitat Hunerbein M, Dubowy A, Raubach M et al (2007) Gradient index ductoscopy and intraductal biopsy of intraductal breast lesions. Am J Surg 194:511–514CrossRefPubMed Hunerbein M, Dubowy A, Raubach M et al (2007) Gradient index ductoscopy and intraductal biopsy of intraductal breast lesions. Am J Surg 194:511–514CrossRefPubMed
20.
21.
Zurück zum Zitat Lang JE, Kuerer HM (2007) Breast ductal secretions: clinical features, potential uses, and possible applications. Cancer Control 14(4):350–359PubMed Lang JE, Kuerer HM (2007) Breast ductal secretions: clinical features, potential uses, and possible applications. Cancer Control 14(4):350–359PubMed
22.
Zurück zum Zitat Pritt B, Pang Y, Kellogg M et al (2004) Diagnostic value of nipple cytology: study of 466 cases. Cancer 102(4):233–238CrossRefPubMed Pritt B, Pang Y, Kellogg M et al (2004) Diagnostic value of nipple cytology: study of 466 cases. Cancer 102(4):233–238CrossRefPubMed
23.
Zurück zum Zitat Kooistra BW, Wauters C, van de Ven S et al (2009) The diagnostic value of nipple discharge cytology in 618 consecutive patients. Eur J Surg Oncol 35(6):573–577PubMed Kooistra BW, Wauters C, van de Ven S et al (2009) The diagnostic value of nipple discharge cytology in 618 consecutive patients. Eur J Surg Oncol 35(6):573–577PubMed
Metadaten
Titel
Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision
verfasst von
Isacco Montroni
Donatella Santini
Giorgia Zucchini
Monica Fiacchi
Simone Zanotti
Giampaolo Ugolini
Alessio Manaresi
Mario Taffurelli
Publikationsdatum
01.10.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0815-1

Weitere Artikel der Ausgabe 3/2010

Breast Cancer Research and Treatment 3/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.